Cargando…
Recanalization Rate and Clinical Outcomes of Intravenous Tissue Plasminogen Activator Administration for Large Vessel Occlusion Stroke Patients
OBJECTIVE: Stroke caused from large vessel occlusion (LVO) has emerged as the most common stroke subtype worldwide. Intravenous tissue plasminogen activator administration (IV-tPA) and additional intraarterial thrombectomy (IA-Tx) is regarded as standard treatment. In this study, the authors try to...
Autores principales: | Lee, Min-Hyung, Im, Sang-Hyuk, Jo, Kwang Wook, Yoo, Do-Sung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurosurgical Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009240/ https://www.ncbi.nlm.nih.gov/pubmed/36825298 http://dx.doi.org/10.3340/jkns.2022.0120 |
Ejemplares similares
-
Prediction of Early Recanalization after Intravenous Thrombolysis in Patients with Large-Vessel Occlusion
por: Kim, Young Dae, et al.
Publicado: (2021) -
Hyperintense Vessel Sign in Large-Vessel Occlusion Stroke of Mild-to-Moderate Severity Ineligible for Recanalization
por: Ryu, Wi-Sun, et al.
Publicado: (2021) -
Early recanalization in large-vessel occlusion stroke patients transferred for endovascular treatment
por: Arrarte Terreros, Nerea, et al.
Publicado: (2022) -
Access to and application of recanalizing therapies for severe acute ischemic stroke caused by large vessel occlusion
por: Bösel, Julian, et al.
Publicado: (2023) -
Recanalization Therapy for Acute Ischemic Stroke with Large Vessel Occlusion: Where We Are and What Comes Next?
por: Shafie, Mohammad, et al.
Publicado: (2021)